Scott Herdman

University of California System — United States

Medicine · Health Sciences

10h-index978citations39works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(22), IL-33, ST2, and ILC Pathways(6), Ion Channels and Receptors(4), Amoebic Infections and Treatments(4), Asthma and respiratory diseases(3)

Publications39 total

Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression
Neoplasia·2026Open Access
Single-cell transcriptomics reveals immune remodeling of the murine lung microenvironment following chronic house dust mite exposure
Frontiers in Immunology·2025· 1 citedOpen Access
Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression
2025Open Access
Supplementary Figure S8 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S9 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S7 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S14 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S12 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S4 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S6 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S2 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S15 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S3 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S11 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S10 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S1 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S17 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S16 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Figure S13 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
Supplementary Table S2 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
2025Open Access
page 1 of 2Next →

Frequent Co-authors

Samuel Bertin(31), Maripat Corr(30), Naoki Takahashi(24), Han Chang(24), Sunandini Sharma(24), Lauren Amaya(23), Sneha Ganguly(23), Matt Levin(23), Zahra Malakoutikhah(23), Miki Yamada‐Hara(23), Arisachi Tanaka(23), Zhihe Wang(22), Ji Won Byun(22), Liping Zeng(22), Minh-Chau Vu(22), David Schwartz(22), Jack Heath(22), Eyal Raz(22), Eyal Raz(13), José M. González‐Navajas(6)